|
- IRMS - Nicolae Testemitanu SUMPh
- 1. COLECȚIA INSTITUȚIONALĂ
- MATERIALE ALE CONFERINȚELOR ȘTIINȚIFICE
- The 19th Edition of the South-East European Ophthalmological Society Congress. October 18-19th, 2024, Chisinau, Republic of Moldova
- The 19th Edition of the South-East European Ophthalmological Society Congress Abstract book. October 18-19th, 2024, Chisinau, Republic of Moldova
Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12710/30520
Title: | Study of the role of P-selectin in the development of diabetic macular edema |
Authors: | Rykov, Sergiy Chuhaiev, Dmytro |
Issue Date: | 2024 |
Publisher: | CEP Medicina |
Citation: | RYKOV, Sergiy; CHUHAIEV, Dmytro. Study of the role of P-selectin in the development of diabetic macular edema. In: The 19th SEEOS Congress: abstract book, Oct. 18-19th, 2024 / org. commit.: Eugeniu Bendelic [et al.].Chişinău: CEP Medicina, 2024, p.63. ISBN 978-9975-82-393-7. |
Abstract: | Introduction: Diabetic retinopathy develops in almost a third of patients with
diabetes. The role of inflammatory and prothrombogenic factors in the
development and progression of diabetic retinopathy has not been fully elucidated.
Purpose: To investigate the role of P-selectin in the development of diabetic macular
edema in diabetic retinopathy and type 2 diabetes.
Methods: We observed 124 patients (124 eyes) with type 2 diabetes mellitus who
had mild (29 eyes, group 1), moderate or severe (35 eyes, group 2) nonproliferative
diabetic retinopathy according to the ETDRS classification and proliferative diabetic
retinopathy (31 eyes, 3rd group). The control group consisted of 29 eyes without
diabetes. All patients underwent comprehensive ophthalmological examinations.
The content of P-selectin in the blood was determined by the immunoenzymatic
method (Invitrogen ThermoFisher Scientific, USA). Statistical processing of the
obtained results was performed using MedStat and MedCalc v.15.1 software
packages (MedCalc Software bvba).
Results: It was established that the blood level of P-selectin in diabetic retinopathy
was statistically significantly increased compared to the control group (by 1.3 times;
p < 0.001). This persisted when stratified only for proliferative diabetic retinopathy.
The increase in P-selectin content had a direct correlation with the level of glycated
hemoglobin and the central thickness of the retina. In proliferative diabetic
retinopathy, the content of P-selectin in the presence of diabetic macular edema
was higher than without it (by 1.2 times; p < 0.001). The association of increased Pselectin content with the development of diabetic macular edema was confirmed in
regression analysis (OR = 1.02; 95% CI 1.01–1.03). ROC analysis showed that this
model had satisfactory criteria only in proliferative DR (AUC = 0.85; 95% CI 0.68–
0.95), which allowed us to calculate the threshold level of prediction, which was
equal to 128.7 ng/ml ( sensitivity of the test is 77.8% and specificity is 69.2%).
Conclusion: Our research established the effect of an increase in P-selectin in the
blood with the development of diabetic macular edema in proliferative diabetic
retinopathy. Based on the obtained results, a prognostic model of the development
of diabetic macular edema in patients with diabetic retinopathy and type 2 diabetes
was developed. |
metadata.dc.relation.ispartof: | The 19th Edition of the South-East European Ophthalmological Society Congress. October 18-19th, 2024, Chisinau, Republic of Moldova |
URI: | http://repository.usmf.md/handle/20.500.12710/30520 |
ISBN: | 978-9975-82-393-7 |
Appears in Collections: | The 19th Edition of the South-East European Ophthalmological Society Congress Abstract book. October 18-19th, 2024, Chisinau, Republic of Moldova
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|